Leadership Team

Managing Partner - Valletta, Malta

Christophe Fabregue is Founder and Managing Partner of HYPERION Life Sciences, M&A and licensing advisory company.

Background: More than 10 years of experience in the pharmaceutical industry: French Drug Regulatory Agency and pharmaceutical companies (Pfizer, Aventis Pharma, Bristol-Myers Squibb); 9 years in M&A-Business development consulting

Network: Executive committee of Pharma Licensing Club France (PLCF) from 2006 to 2012, and active member of the European Pharma Licensing Club (EPLC) and PLG UK

Teaching: Head of «M&A, Business Development & Licensing» courses in top French business school: ESCP Europe (Master in pharmaceutical management)

Education: MS Economics, and BA - Institut d’Etudes Politiques; Sorbonne University; ESCP Europe Business School; Corporate Finance Strategy program – Insead

Core competencies: Divestitures – Acquisitions – Licensing

Senior Partner - Lisbon, Portugal

Antoine Ortoli is Senior Partner of HYPERION Life Sciences, he has the responsibility of co-leading Hyperion deals in Emerging Markets.

Background: 33 years at Sanofi as top executive through different positions:

• CFO of the Pharma Division
• General Manager in Europe
• VP for Latin America and then for Africa-Middle East, Eastern Countries and Asia
• Senior VP Operations for Intercontinental region (90 countries under management)
• Chairman of the Strategic Emerging Markets Committee

Core Competences and M&A credential : Business Strategy, Strategic Marketing, BD & Alliances, Integration-Restructuring Change Management and Big team Leadership.

Education: Neoma business school (1976) ; Chartered accountant (1980) ; Insead (AMP 93)

Senior Advisor - Paris, France

Claude Perol is Senior Advisor of HYPERION Life Sciences. He has an in-depth experience of international pharma industry of more than 30 years.

Background: He worked mainly at Sanofi as top executive through different leadership positions:

• Head of Established Products Franchise (10 billion euros; 2014-2016)
• VP Central & Eastern Europe (1.5 billion euros; 2007-2014)
• Head of Business Excellence Pharma (2000-2005)
• Head of Generic Division (1993-1999)
• Health Strategy Head at Elf group (1989-1993)
• Leader of the Hepatitis B Jventure in Taiwan (1984-1987)

Education: Doctor in Pharmacy; MBA Insead (1982)

Partner - Spain, Russia

Joel Lautier joined Hyperion in 2018 as Partner to develop in particular the operations in the Spanish market. He is the founder and head of RGG Capital, a M&A and corporate finance advisory firm based in Moscow, with a large cross-border deal experience.
He has extensive experience in corporate mergers, takeovers and asset disposals, both on the buy-side and sell-side, and has closed large transactions with a deal size above 500 million euros. He has worked with family owned midsize pharmaceutical companies, as well as large multinational pharmaceutical firms with a turnover above 5 billion USD, on various types of deals, such as asset purchases, in-licensing and out-licensing contracts. He is a member of the board of directors of the French-Russian Chamber of Commerce and Industry, and is on the board of several private and public companies in the industries of chemicals, electric equipment and financial services.

Background: Senior positions since 2006 in management consulting and financial advisory. Has had a distinguished career in chess, having been one of the top ten players in the world, with a lifetime positive score against former World Champion Garry Kasparov. Currently resides in Barcelona (Spain).

Education: Studied M&A and finance at the Wharton business school (Philadelphia, USA) in 2008. In 2014, he graduated with an Executive MBA degree (with honors) from the Skolkovo Moscow School of Management, Russia's top international business school.